Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Hansol Chemical (014680 KS)
Watchlist
29
Analysis
Materials
•
South Korea
Hansol Chemical Co., Ltd. manufactures chemical products such as hydrogen peroxide, benzol peroxide, urea resin, polyacrylamide, trimethylolpropane, and latex. The Company supplies its products to the paper, textile, and food industries.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
08 Oct 2026 16:30
KRX Short Interest Weekly (Oct 2nd): HLB, DWEC, NAVER, Samsung Elec (PREF), Doosan Enerbility
We analyzed KRX short interest report for the past week and highlighted short interest changes in HLB, DWEC, NAVER, Samsung Elec (PREF), Doosan...
Ke Yan, CFA, FRM
Follow
93 Views
Share
bullish
•
Cross Asset Strategy
•
20 May 2021 15:12
Screening the Silk Road: Q2-2021 All Cap GARP (Zulu Warrior Screening)
GARP selection, held for 12 mths for good reason. The list delivered an average return of 54% v’s the MSCI Asia Pac Index 37.4% over the same...
David Lepper
557 Views
Share
bullish
•
Celltrion Inc
•
02 Jul 2026 06:41
Alpha Generation Through Share Buybacks in Korea: Bi-Monthly (May & June 2026)
​Analysis of alpha generation through share buybacks in Korean stock market, highlighting 59 companies with buyback programs in May and June 2026.
Douglas Kim
Follow
145 Views
Share
bearish
•
Cross Asset Strategy
•
01 Jul 2020 06:11
Korea Stock Market Monthly Recap #49 (June 2020)
Review of Top 10 Issues Related to Korean stock market, economy, & politics in June 2020: SK Biopharm IPO SK Holdings downgrade Capital gains...
Douglas Kim
Follow
532 Views
Share
bearish
•
Cross Asset Strategy
•
18 Jun 2020 09:36
"Buy the Rumor" Of Upcoming KOSPI200 Rebalance in 12/2020 & "Sell the News" Of 6/2020
In this insight, we provide an analysis of "buying the rumor" of potential additions to the next KOSPI200 rebalance in December 2020 as well...
Douglas Kim
Follow
470 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x